Discover 3,465 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,465
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Location: Los Angeles CA, Orange CA, La Jolla CA, Phoenix AZ,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05735184
Phase1, Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Los Angeles CA, Orange CA, San Francisco CA, Gilbert AZ,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase1, Recruiting
Child Bipolar Network Ketogenic Diet Approach to Bipolar Disorder in Adolescents
for
Bipolar Disorder (BD), Bipolar Disorder NOS,
Location: Los Angeles CA, Cincinnati OH
Sponsor: University of California, Los Angeles
Sex: All
Age: 12 - 21
Code: NCT06920940
Recruiting
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
for
Amblyopia
Location: Los Angeles CA, Fullerton CA, Pomona CA, Irvine CA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 4 - 7
Code: NCT06380517
Phase3, Recruiting
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
for
Macular Edema Secondary to Inflammation
Location: Los Angeles CA, Glendale CA, Pasadena CA, Oxnard CA,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06990399
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
for
Macular Edema Secondary to Inflammation
Location: Los Angeles CA, Glendale CA, Pasadena CA, Oxnard CA,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT06996080
Phase3, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Location: Los Angeles CA, Beverly Hills CA, Torrance CA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT06541704
Phase3, Recruiting
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
for
Arrythmia, Cardiomyopathies
Location: Los Angeles CA, San Francisco CA, Phoenix AZ,
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT05034432
Recruiting
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
for
Pouchitis, Pouches, Ileoanal, Pouch, Ileal
Location: Los Angeles CA, Rochester MN, Chapel Hill NC,
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18 - 70+
Code: NCT06864403
Recruiting
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Los Angeles CA, San Francisco CA, Phoenix AZ,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07491445
Phase3, Recruiting
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Los Angeles CA, Fullerton CA, San Francisco CA,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06203210
Phase3, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Los Angeles CA, Burbank CA, Irvine CA, Santa Barbara CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase3, Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Los Angeles CA, Los Alamitos CA, Irvine CA, La Jolla CA,